v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues:    
Product revenue, net $ 137,250 $ 0
Operating expenses:    
Cost of sales 4,513 0
Research and development 44,172 71,237
Selling, general and administrative 167,876 80,800
Total operating expenses 216,561 152,037
Loss from operations (79,311) (152,037)
Interest income 9,370 8,334
Interest expense (3,297) (3,838)
Net loss $ (73,238) $ (147,541)
Net loss per common share:    
Basic net loss per common share (in dollars per share) $ (3.32) $ (7.38)
Diluted net loss per common share (in dollars per share) $ (3.32) $ (7.38)
Basic weighted average number of common shares outstanding (in shares) 22,091,314 20,001,569
Diluted weighted average number of common shares outstanding (in shares) 22,091,314 20,001,569